Name Letrozole

CAS 112809-51-5

EINECS(EC#) 675-034-8

Molecular Formula C17H11N5

MDL Number MFCD00866241

Molecular Weight 285.3

Appearance white to off-whitecrystalline powder

Features Letrozole(112809-51-5) is an oral non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer.

Melting point 181-183°C

Boiling point 563.5±60.0 °C(Predicted)

density 1.21±0.1 g/cm3(Predicted)

storage temp. 2-8°C

HOT SELLING

Semaglutide CAS 910463-68-2

Tirzepatide CAS 2023788-19-2

Retatrutide CAS 2381089-83-2

Liaglutide CAS 204656-20-2

Octreotide CAS79517-01-4

Dulaglutide CAS 923950-08-7

LixisenatideAcetate CAS 320367-13-3

Teduglutide CAS 197922-42-2

Albiglutide CAS 782500-75-8

Degarelix CAS 214766-78-6

Cilengitide CAS 188968-51-6

Mifamurtide CAS 83461-56-7

Somatostatin CAS 51110-01-1

Exenatide Acetate CAS 141732-76-5

Pramlintide CAS 151126-32-8

Eptifibatide CAS 188627-80-7

Bivalirudin CAS 128270-60-0

Semax CAS 80714-61-0